In the Strong Heart Family Study, sphingolipids were evaluated with both baseline and follow-up analyses of plasma insulin, HOMA of insulin resistance (HOMA-IR) and HOMA of β-cell function (HOMA-B) after adjustment for risk factors. The gene discussed is INS; the disease is Insulin resistance.